The current study not only improves our understanding of the pathologic mechanisms of how LAMP2 deficiency contributes to cardiac phenotypes but also provides novel therapeutic targets to prevent arrythmia in DD patients. This evidence concerns the gene LAMP2 and cardiac arrhythmia.